Baricitinib in the Treatment of Adults With Pyoderma Gangrenosum (PG)
Condition(s):Pyoderma Gangrenosum; Skin Diseases; Wound Heal; Pyoderma; Skin UlcerLast Updated:October 26, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Pyoderma Gangrenosum; Skin Diseases; Wound Heal; Pyoderma; Skin UlcerLast Updated:October 26, 2023Recruiting
Condition(s):Mastitis Chronic; Idiopathic Granulomatous MastitisLast Updated:May 10, 2023Recruiting
Condition(s):Covid19; Corona Virus InfectionLast Updated:February 29, 2024Recruiting
Condition(s):Frontal Fibrosing AlopeciaLast Updated:February 8, 2024Not yet recruiting
Condition(s):Rheumatoid ArthritisLast Updated:April 25, 2023Recruiting
Condition(s):Immune ThrombocytopeniaLast Updated:June 13, 2023Recruiting
Condition(s):Amyotrophic Lateral Sclerosis; Alzheimer Disease; Mild Cognitive ImpairmentLast Updated:March 19, 2024Recruiting
Condition(s):Lichen Planus, Oral; Lichen Planus, Mucosal; Oral Lichen PlanusLast Updated:March 28, 2024Recruiting
Condition(s):Immune ThrombocytopeniaLast Updated:July 12, 2023Recruiting
Condition(s):Hospital-acquired PneumoniaLast Updated:June 22, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.